Clinical Trials Browser

Phase 1/2 × Lymphoma, B-Cell, Marginal Zone × CTLA-4 Antigen × Clear all

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT00089076 2014-05-30

MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma

Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Intraocular Lymphoma

Clinical Trials

A Phase I/II Study of Intratumoral Injection of SD-101

MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma